Clinical Trial Update: Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for aripiprazole in treating pervasive developmental disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pervasive Developmental Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Indiana University | Conditions: Pervasive Developmental Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-11-28